Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ProQR Therapeutics
ProQR Therapeutics
Interest in RNA Editing Accelerates as Therapies Approach the Clinic
BioSpace
Wed, 10/18/23 - 11:37 am
RNA editing
Alnylam
Shape Therapeutics
Eli Lilly
ProQR Therapeutics
ProQR sale of eye drugs comes undone over employment contracts
BioPharma Dive
Wed, 09/27/23 - 11:50 am
ProQR Therapeutics
Laboratoires Théa
employment contracts
Lilly doubles down on ProQR's RNA tech in $75M deal expansion, spurring biotech's much-needed share rally
Fierce Biotech
Thu, 12/22/22 - 10:58 am
Eli Lilly
ProQR Therapeutics
genetic medicine
RNA
Band of biotechs cut pipeline prospects to focus cash on priority programs
Fierce Biotech
Thu, 08/11/22 - 11:30 pm
ProQR Therapeutics
Harpoon Therapeutics
Kala Pharmaceuticals
Synthetic Biologics
Just months after layoffs and pushing eye therapy, ProQR offloads eye portfolio in pivot to RNA-editing
Endpoints
Thu, 08/11/22 - 12:05 pm
ProQR Therapeutics
RNA editing
ProQR Shares Crater After Disappointing Sepofarsen Data In Inherited Vision Loss Disorder
Benzinga
Fri, 02/11/22 - 11:44 am
ProQR Therapeutics
sepofarsen
vision disorder
ProQR eyes its first big test
EP Vantage
Fri, 01/14/22 - 11:02 am
ProQR Therapeutics
Leber's congenital amaurosis
blindness
sepofarsen
Key data reveals for the small players
EP Vantage
Mon, 12/27/21 - 11:18 am
Nordic Nanovector
Betalutin
ProQR Therapeutics
sepofarsen
Praxis
PRX-114
Eli Lilly Pursues RNA Editing in New Partnership with ProQR
Xtalks
Mon, 09/13/21 - 10:43 am
Eli Lilly
RNA
gene editing
ProQR Therapeutics
Eli Lilly follows up MiNA pact with a 2nd $1B-plus RNA collab, this time with ProQR
Fierce Biotech
Wed, 09/8/21 - 11:28 pm
Eli Lilly
RNA
gene silencing
ProQR Therapeutics
Proqr hopes to usher in a new ophthalmic therapy
EP Vantage
Mon, 03/29/21 - 10:26 am
ProQR Therapeutics
QR-421a
Usher Syndrome
clinical trials
ProQR’s RNA therapy on track to pivotal tests in rare, inherited form of vision loss
MedCity News
Wed, 03/24/21 - 11:17 pm
ProQR Therapeutics
Usher Syndrome
clinical trials
RNA therapy
ProQR spins out skin disease drug into nonprofit-backed startup
Fierce Biotech
Wed, 03/27/19 - 11:38 am
ProQR Therapeutics
Wings Therapeutics
spinoffs
non-profts
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Adamis
GSK
Sangamo BioSciences
Roche
Bluebird Bio
ProQR Therapeutics
Geron
Amarin
Palatin
EyeGate
Galactin
Omeros
Atossa Genetics
What’s Wrong With Vertex?
Barron's
Fri, 09/18/15 - 09:11 pm
Vertex Pharmaceuticals
ProQR Therapeutics
Galapagos